The Medicines Company (NASDAQ:MDCO) will host a conference call on Tuesday, February 28, 2017, at 8:30 a.m., Eastern Time, to discuss fourth-quarter and full-year 2016 financial results and operational developments.

The dial-in information to access the call is listed below:

U.S./Canada: (877) 359-9508International: (224) 357-2393Conference ID: 66296847

A taped replay of the conference call will be available from 11:30 a.m., Eastern Time, following the conference call until 11:30 a.m., Eastern Time, on March 7, 2017. The replay may be accessed as follows:

U.S./Canada: (855) 859-2056International: (404) 537-3406Conference ID: 66296847

The webcast can be accessed in the Investors section of The Medicines Company website. A replay of the webcast will also be available.

About The Medicines Company

The Medicines Company is a biopharmaceutical company driven by an overriding purpose — to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s mission is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in three critical therapeutic areas: serious infectious disease care, cardiovascular care and surgery and perioperative care. The Company is headquartered in Parsippany, New Jersey, with global innovation centers in California and Switzerland.

The Medicines CompanyMediaMeg LanganVice President, 973-290-6319margaret.langan@themedco.comorInvestor RelationsKrishna Gorti, M.D., 973-290-6122Vice President, Investor Relationskrishna.gorti@themedco.com

Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Medicines Charts.
Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Medicines Charts.